Intestinimonas butyriciproducens - Caelus Health
Latest Information Update: 18 Mar 2025
At a glance
- Originator Caelus Health
- Class Antihyperglycaemics; Bacteria
- Mechanism of Action Gastrointestinal microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Type 2 diabetes mellitus